Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 1997

View Archived Issues

Lexicon Genetics granted NIH grant for DNA repair research

ImClone Systems earns manufacturing milestone from Merck KGaA

Iloprost reverses 5-FU-induced delayed wound healing in rats

Ergoset improves metabolism in healthy obese women

Grepafloxacin receives first approval in Germany

Rhone-Poulenc Rorer: Q2 1997 highlights

Nutraceutix in-licenses breast cancer preventive agent

Stanford scientists report breakthrough in polyketide research

New oxazolidinones from P&U

Merck & Co. discloses new substance P antagonists

Janssen reports farnesyl protein transferase inhibitors

Zeneca's Seroquel deemed approvable by FDA

Crinone approved in U.S. for additional indication

Access and The Dow Chemical Company enter into collaboration

Apoptosis Technology and BioChem Pharma to collaborate on anticancer agents

Alteon's pimagedine progresses to phase III

HCV virus isolated and cloned for the first time

Generic warfarin shipments begin

CE certification attained for Carrington Patch; European launch in sight

Seven more marketing approvals announced for Campto

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...